These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 25155887)

  • 1. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
    He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations of SOST mRNA expression in human bone are associated with DNA polymorphism and DNA methylation in the SOST gene.
    Lhaneche L; Hald JD; Domingues A; Hannouche D; Delepine M; Zelenika D; Boland A; Ostertag A; Cohen-Solal M; Langdahl BL; Harsløf T; de Vernejoul MC; Geoffroy V; Jehan F
    Bone; 2016 Nov; 92():107-115. PubMed ID: 27519970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women.
    Velázquez-Cruz R; Jiménez-Ortega RF; Parra-Torres AY; Castillejos-López M; Patiño N; Quiterio M; Villarreal-Molina T; Salmerón J
    BMC Musculoskelet Disord; 2014 Nov; 15():400. PubMed ID: 25430630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of sclerostin and secreted frizzled protein polymorphisms with bone mineral density: an association study with replication in postmenopausal women.
    Valero C; Zarrabeitia MT; Hernández JL; Pineda B; Cano A; García-Pérez MA; Riancho JA
    Menopause; 2011 Jul; 18(7):802-7. PubMed ID: 21441835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.
    Polyzos SA; Anastasilakis AD; Bratengeier C; Woloszczuk W; Papatheodorou A; Terpos E
    Osteoporos Int; 2012 Mar; 23(3):1171-6. PubMed ID: 21305266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
    Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.
    Szulc P; Bertholon C; Borel O; Marchand F; Chapurlat R
    J Bone Miner Res; 2013 Apr; 28(4):855-64. PubMed ID: 23165952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of polymorphisms in the SOST gene and bone mineral density in postmenopausal Chinese Women.
    Zhang H; He JW; Wang C; Zhang Z; Yue H; Hu WW; Gu JM; Hu YQ; Li M; Fu WZ; Zhang ZL
    Osteoporos Int; 2014 Dec; 25(12):2797-803. PubMed ID: 25103216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic Analyses of the Sclerostin rs851056 and Dickkopf rs1569198 Polymorphisms in Mexican-Mestizo Postmenopausal Osteoporosis: A Case-Control Study.
    Vazquez-Villegas ML; Rodriguez-Jimenez NA; Contreras-Haro B; Vasquez-Jimenez JC; Perez-Guerrero EE; Moran-Moguel MC; Sánchez-Rodríguez EN; Villagómez-Vega A; Nuño-Arana I; Becerra-Alvarado IN; Rubio-Arellano ED; Nava-Valdivia CA; Ponce-Guarneros JM; Fajardo-Robledo NS; Nava-Zavala AH; Gonzalez-Lopez L; Saldaña-Cruz AM
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):211-217. PubMed ID: 33734895
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
    Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
    J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.
    Recker RR; Benson CT; Matsumoto T; Bolognese MA; Robins DA; Alam J; Chiang AY; Hu L; Krege JH; Sowa H; Mitlak BH; Myers SL
    J Bone Miner Res; 2015 Feb; 30(2):216-24. PubMed ID: 25196993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.
    Lim Y; Kim CH; Lee SY; Kim H; Ahn SH; Lee SH; Koh JM; Rhee Y; Baek KH; Min YK; Kim DY; Kim BJ; Kang MI
    Calcif Tissue Int; 2016 Oct; 99(4):350-9. PubMed ID: 27289555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis.
    Ueland T; Stilgren L; Bollerslev J
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.
    Guañabens N; Ruiz-Gaspà S; Gifre L; Miquel R; Peris P; Monegal A; Dubrueil M; Arias A; Parés A
    J Bone Miner Res; 2016 Sep; 31(9):1725-33. PubMed ID: 27019303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
    Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
    J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
    Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.